Altimmune To Test Investigational GLP-1–Based Obesity Drug for Alcohol Use Disorder BioSpace
Month: March 2025
Purim Shpiel: New cutting-edge weight loss procedure takes the world by storm – The Jerusalem Post
Purim Shpiel: New cutting-edge weight loss procedure takes the world by storm The Jerusalem Post
Consumers’ Expectations about GLP-1 Drugs Economic Impact on Food System Players – University of Illinois Urbana-Champaign
Consumers’ Expectations about GLP-1 Drugs Economic Impact on Food System Players University of Illinois Urbana-Champaign
DPP4 and GLP-1: The Dynamic Duo in Diabetes Management
Dipeptidyl peptidase-4 (DPP4) is an enzyme that plays a crucial role in glucose metabolism and the…
Video FBI warns about counterfeit weight loss drugs – ABC News
Video FBI warns about counterfeit weight loss drugs ABC News
Healthy Eating: GLP-1 Diet for Celebs
**Title: The GLP-1 Diet: A Celebrity Trend Transforming Health and Wellness** **The GLP-1 diet is rooted…
MeiraGTx and Hologen launch AI-backed gene therapy venture
The venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase III trials with up to…
6 common weight loss myths busted: Expert explains the reasoning behind popular claims – Hindustan Times
6 common weight loss myths busted: Expert explains the reasoning behind popular claims Hindustan Times
Weight Loss Isn’t Always Healthy? Study Finds It Can Be Deadly for Some Patients – SciTechDaily
Weight Loss Isn’t Always Healthy? Study Finds It Can Be Deadly for Some Patients SciTechDaily
EC approves Otsuka and Lundbeck’s Rxulti for schizophrenia
The EC has approved Otsuka Pharmaceutical and Lundbeck’s atypical oral antipsychotic, Rxulti (brexpiprazole), for treating schizophrenia.